Classifying patients with Behçet's disease for disease severity, using a discriminating analysis method

Clin Exp Dermatol. 2009 Mar;34(2):151-5. doi: 10.1111/j.1365-2230.2008.02811.x.

Abstract

Background: Interleukin (IL)-8 has been shown to correlate with the activity of Behçet's disease (BD). The aim of this study was to develop tools as reliable as IL-8 levels in defining BD severity.

Methods: In total, 32 patients with BD and 16 healthy controls were included in the study. Medical history, physical examination, routine laboratory investigations and measurement of serum IL-8 levels were performed. The patients were classified as groups I and II based on the serum IL-8 levels. The patients were then reassigned to groups based on the predictions through discriminating analysis.

Results: In addition to the differences between patient and control groups, the differences between groups I and II, group I and controls, and group II and controls were statistically significant. The discriminating analysis results showed that the patients had been assigned to groups I and II with 100% accuracy.

Conclusion: Discriminating analysis using clinical and routine laboratory findings indicated that 100% of the patients were accurately assigned to the same groups as their IL-8 levels indicated. This suggests that the classification made according to discriminating analysis using these routine variables is a reliable method in determination of the disease severity.

MeSH terms

  • Adult
  • Behcet Syndrome / classification*
  • Behcet Syndrome / genetics
  • Biomarkers / blood
  • Discriminant Analysis
  • Female
  • Humans
  • Immunohistochemistry
  • Interleukin-8 / blood*
  • Interleukin-8 / genetics
  • Male
  • Middle Aged
  • Prognosis
  • Severity of Illness Index
  • Young Adult

Substances

  • Biomarkers
  • Interleukin-8